Central Serous Chorioretinopathy

Introducing an optimized treatment paradigm

Due to its ability to overlay ICG angiographies and FA images for precise planning, Navilas provides a unique and advanced treatment paradigm for central serous chorioretinopathy. In conjunction with the ability to perform subthreshold treatments Navilas represents an optimal tool to target central serous chorioretinopathy.

Easy Targeting

Indocyanine green angiography images, fluorescein images as well as OCT images can be overlaid to correctly identify the leakage cause and target the appropriate lesion adequately while minimally damaging healthy tissue.

Optimized Results

An intertrial study comparison demonstrated that the use of navigated threshold laser results in an earlier and higher closure rate of leakage points as compared to conventional lasers.

Feasible sub-threshold approach

Ensuring confluency and traceability

Navilas provides full documentation of each applied spot with respect to parameters as well as spot position relative to macula and optical nerve head, thus ensuring for the first time true traceability and enabling potential re-treatment.

With pre-planned laser positions and automatic execution of laser spots it can ensure that the correct tissue is activated and remodeled.

References

  1. Microsecond Yellow Laser for Subfoveal Leaks in Central Serous Chorioretinopathy. Ambiya, Vikas, Abhilash Goud, Annie Mathai, Padmaja Kumari Rani, and Jay Chhablani. Clinical Ophthalmology (Auckland, N.Z.) 10 (August 11, 2016): 1513. PubMed PMID: 27570446 
    Read more
  2. Comparison of Photodynamic Therapy and Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy. Ntomoka, Cyprian Gabriel, Bindu Rajesh, Gachago Muchai Muriithi, Abhilash Goud, and Jay Chhablani. Eye, February 12, 2018. PubMed PMID: 29429986 
    Read more
  3. Central Serous Chorioretinopathy Treated With Navigated Retinal Laser Photocoagulation: Visual Acuity and Retinal Sensitivity. Mastropasqua, Leonardo, Luca Di Antonio, Lisa Toto, Alessandra Mastropasqua, Angelo Di Iorio, and Paolo Carpineto. "Ophthalmic Surgery, Lasers and Imaging Retina 46, no. 3 (March 1, 2015): 349-54. PubMed PMID: 25856822 
    Read more
  4. Navigated Focal Laser Photocoagulation for Central Serous Chorioretinopathy. Chhablani, Jay, Padmaja Kumari Rani, Annie Mathai, Subhadra Jalali, and Igor Kozak. "Clinical Ophthalmology, August 2014, 1543. PubMed PMID: 25170248 
    Read more
  5. Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy. Müller, B., Tatsios, J., Klonner, J., Pilger, D., & Joussen, A. M. (2018). Graefe's Archive for Clinical and Experimental Ophthalmology, 1-8. PubMed PMID: 29876733 
    Read more
  6. Klon 2016: Navigated retinal photocoagulation (Navilas®) as an alternative therapy in patients with refractory central serous chorioretinopathy. Jan Klonner, Juliane Schlomberg, Anne Rübsam, Tina DietrichNtoukas, Sibylle Winterhalter, Antonia Joussen, Bert Müller. Department of Ophthalmology, Charité - Medical University Berlin Campus Virchow, Berlin, Germany. ARVO 2016 Poster 
  7. Lim 2010: Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy. Lim JW, Kang SW, Kim YT, Chung SE, Lee SW. British Journal of Ophthalmology. 2010
    Read more
  8. Buru 1997: Laser Photocoagulation for Persistent Central Serous Retinopathy: results of long-term follow-up. Burumcek E, Mudun A, Karacorlu S, Arslan MO. Ophthalmology 1997; 104:616-622
    Read more 
  9. Rob 1983: Direct, indirect and sham laser photocoagulation in the management of central serous chorioretinopathy. Robertson and Ilstrup. American Journal of Ophthalmology 95:457-66, 1983
    Read more
Company

Learn how to make navigated laser work for you

Contact the Navilas® team